BamSEC and AlphaSense Join Forces
Learn More

Prelude Therapeutics Incorporated – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: PRLD    
Share price (6/12/26): $4.49    
Market cap (6/12/26): $358 million

Plans of Reorganization, Merger, Acquisition or Similar

No filings in this category.